Dina Tiniakos

2002–2026 年に発表

81
論文数
18,162
被引用数
52
h 指数
75
i10 指数

被引用数

Dina Tiniakos の年別被引用数1982 年: 被引用 1 件1983 年: 被引用 1 件1994 年: 被引用 1 件2003 年: 被引用 1 件2004 年: 被引用 4 件2005 年: 被引用 6 件2006 年: 被引用 2 件2008 年: 被引用 3 件2009 年: 被引用 13 件2010 年: 被引用 27 件2011 年: 被引用 30 件2012 年: 被引用 23 件2013 年: 被引用 27 件2014 年: 被引用 42 件2015 年: 被引用 54 件2016 年: 被引用 80 件2017 年: 被引用 110 件2018 年: 被引用 124 件2019 年: 被引用 317 件2020 年: 被引用 486 件2021 年: 被引用 690 件2022 年: 被引用 810 件2023 年: 被引用 913 件2024 年: 被引用 1,983 件2025 年: 被引用 1,106 件2026 年: 被引用 38 件1984〜1993 年は被引用が無いため表示していません1995〜2002 年は被引用が無いため表示していません2007 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,014 件、この内訳の 18.2%中国: 引用元論文 1,480 件、この内訳の 13.4%イギリス: 引用元論文 789 件、この内訳の 7.2%イタリア: 引用元論文 677 件、この内訳の 6.1%ドイツ: 引用元論文 550 件、この内訳の 5%日本: 引用元論文 393 件、この内訳の 3.6%スペイン: 引用元論文 391 件、この内訳の 3.5%フランス: 引用元論文 342 件、この内訳の 3.1%韓国: 引用元論文 305 件、この内訳の 2.8%オーストラリア: 引用元論文 246 件、この内訳の 2.2%カナダ: 引用元論文 223 件、この内訳の 2%スウェーデン: 引用元論文 203 件、この内訳の 1.8%
0%18.2%その他 31.1%

分野

  • Medicine82.5%
  • Biochemistry, Genetics and Molecular Biology10.4%
  • Immunology and Microbiology3.5%
  • Neuroscience1%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Computer Science0.5%
  • その他1.6%

トピック

  • Liver Disease Diagnosis and Treatment21.9%
  • Liver Disease and Transplantation5.7%
  • Diet, Metabolism, and Disease5%
  • Liver Diseases and Immunity3.4%
  • Alcohol Consumption and Health Effects3.3%
  • Hepatocellular Carcinoma Treatment and Prognosis3%
  • その他57.7%

共著者

全論文

検索で開く
  1. A multisociety Delphi consensus statement on new fatty liver disease nomenclature

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marko Korenjak, Kris V. Kowdley, Florence Lacaille, Rohit Loomba, Robert Mitchell-Thain, Timothy R. Morgan, Elisabeth E. Powell, Michael Roden, Manuel Romero‐Gómez, Marcelo Silva, Shivaram Prasad Singh, Silvia Sookoian, C Wendy Spearman, Dina Tiniakos, Luca Valenti, Miriam B. Vos, Vincent Wai‐Sun Wong, Stavra A. Xanthakos, Yusuf Yılmaz, Zobair M. Younossi, Ansley Hobbs, Marcela Villota‐Rivas, Philip N. Newsome, on behalf of the NAFLD Nomenclature consensus group - Hepatology 2023 被引用: 2,904

  2. A multisociety Delphi consensus statement on new fatty liver disease nomenclature

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marko Korenjak, Kris V. Kowdley, Florence Lacaille, Rohit Loomba, Robert Mitchell-Thain, Timothy R. Morgan, Elisabeth E. Powell, Michael Roden, Manuel Romero‐Gómez, Marcelo Silva, Shivaram Prasad Singh, Silvia Sookoian, C Wendy Spearman, Dina Tiniakos, Luca Valenti, Miriam B. Vos, Vincent Wai‐Sun Wong, Stavra A. Xanthakos, Yusuf Yılmaz, Zobair M. Younossi, Ansley Hobbs, Marcela Villota‐Rivas, Philip N. Newsome - Annals of Hepatology 2023 被引用: 2,698

  3. NASH limits anti-tumour surveillance in immunotherapy-treated HCC

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pierre Bédossa, Simon Cockell, Ramy Younes, Michèle Vacca, Fabio Marra, Jörn M. Schattenberg, Michael Allison, Elisabetta Bugianesi, Vlad Ratziu, Tiziana Pressiani, Antonio D’Alessio, Nicola Personeni, Lorenza Rimassa, Ann K. Daly, Bernhard Scheiner, Katharina Pomej, Martha M. Kirstein, Arndt Vogel, Markus Peck‐Radosavljevic, Florian Hucke, Fabian Finkelmeier, Oliver Waidmann, Jörg Trojan, Kornelius Schulze, Henning Wege, Sandra Koch, Arndt Weinmann, Marco Bueter, Fabian Rössler, Alexander Siebenhüner, Sara De Dosso, Jan‐Philipp Mallm, Viktor Umansky, Manfred Jugold, Tom Luedde, Andrea Schietinger, Peter Schirmacher, Brinda Emu, Hellmut G. Augustin, Adrian T. Billeter, Beat P. Müller‐Stich, Hiroto Kikuchi, Dan G. Duda, Fabian Kütting, Dirk‐Thomas Waldschmidt, Matthias Ebert, Nuh N. Rahbari, Henrik E. Mei, Axel Schulz, Marc Ringelhan, Nisar P. Malek, Stephan Spahn, Michael Bitzer, Marina Ruiz de Galarreta, Amaia Lujambio, Jean‐François Dufour, Thomas U. Marron, Ahmed O. Kaseb, Masatoshi Kudo, Yi‐Hsiang Huang, Nabil Djouder, Katharina Wolter, Lars Zender, Parice N. Marche, Thomas Decaens, David J. Pinato, Roland Rad, Joachim C. Mertens, Achim Weber, Kristian Unger ほか 10 名 - Nature 2021 被引用: 1,280

  4. Cellular senescence drives age-dependent hepatic steatosis

    著者: , , , , , , , , , , , , , , , , , , , - Nature Communications 2017 被引用: 1,036

  5. Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis

    著者: , , , , , , , , , , , , , , , - The American Journal of Gastroenterology 2016 被引用: 891

  6. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2020 被引用: 454

  7. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2020 被引用: 514

  8. Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guruprasad P. Aithal, Jörn M. Schattenberg, Elisabetta Bugianesi, Manuel Romero‐Gómez, Vlad Ratziu, Quentin M. Anstee, Patrick M. Bossuyt - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 196

  9. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Vlad Ratziu, Karine Clément, Raluca Pais, Detlef Schuppan, Jörn M. Schattenberg, Toni Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas, Evangelia Petsalaki, Matej Orešič, Tuulia Hyötyläinen, Aiden McGlinchey, José M. Mato, Óscar Millet, Jean‐François Dufour, Annalisa Berzigotti, Michael Pavlides, Stephen A. Harrison, Stefan Neubauer, Jeremy Cobbold, Ferenc E. Mózes, Salma Akhtar, Rajarshi Banerjee, Matt Kelly, Elizabeth Shumbayawonda, Andrea Dennis, Charlotte Erpicum, Manuel Romero‐Gómez, Emilio Gómez-González, Javier Ampuero, Javier Castell, Rocío Gallego‐Durán, Isabel Fernández-Lizaranzu, Rocío Montero‐Vallejo, M.A. Karsdal, Elisabeth Erhardtsen, Daniel Guldager Kring Rasmussen, Diana Julie Leeming, Mette Juul Fisker, Antonia Sinisi, Kishwar Musa, Fay Betsou, Estelle Sandt, Manuela Tonini, Elisabetta Bugianesi, Chiara Rosso, Angelo Armandi, Fabio Marra, Amalia Gastaldelli, Gianluca Svegliati, Jérôme Boursier, Sven Francque, Luisa Vonghia, Mattias Ekstedt, Stergios Kechagias, Hannele Yki‐Järvinen, Panu K. Luukkonen, Saskia W. C. van Mil, George Papatheodoridis, Helena Cortez‐Pinto, Luca Valenti, Salvatore Petta, Luca Miele, Andreas Geier ほか 35 名 - Journal of Hepatology 2021 被引用: 353

  10. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hannes Hagström, Camilla Akbari, Masashi Hirooka, Wah‐Kheong Chan, Sanjiv Mahadeva, Ruveena Bhavani Rajaram, Ming‐Hua Zheng, Jacob George, Mohammed Eslam, Salvatore Petta, Grazia Pennisi, Mauro Viganò, Sofia Ridolfo, Guruprasad P. Aithal, Naaventhan Palaniyappan, Dae Ho Lee, Mattias Ekstedt, Patrik Nasr, Christophe Cassinotto, Victor de Lédinghen, Annalisa Berzigotti, Yuly P. Mendoza, Mazen Noureddin, Emily Truong, Céline Fournier‐Poizat, Andreas Geier, Miljen Martić, Theresa Tuthill, Quentin M. Anstee, Stephen A. Harrison, Patrick M. Bossuyt, Michael Pavlides, Quentin M. Anstee, Ann K. Daly, Olivier Govaere, Simon Cockell, Dina Tiniakos, Pierre Bédossa, Alastair D. Burt, Fiona Oakley, Heather J. Cordell, Christopher P. Day, Kristy Wonders, Paolo Missier, Matthew McTeer, Luke Vale, Yemi Oluboyede, Matt Breckons, Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Max Nieuwdorp, Adriaan G. Holleboom, Joanne Verheij, Vlad Ratziu, Karine Clément, Rafael Patiño‐Navarrete, Raluca Pais, Valérie Paradis, Detlef Schuppan, Jörn M. Schattenberg, Rambabu Surabattula, Sudha Rani Myneni, Beate K. Straub, Toni Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas ほか 130 名 - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 187

  11. An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marta B. Afonso, Ramy Younes, Yuichiro Amano, Scott L. Friedman, Shuang Wang, Dipankar Bhattacharya, Eric J. Simon, Valérie Paradis, Alastair D. Burt, Ioanna Maria Grypari, Susan Davies, Ann Driessen, Hiroaki Yashiro, Susanne Elisabeth Pors, M Andersen, Michael Feigh, Carla Yunis, Pierre Bédossa, Michelle Stewart, Heather Cater, Sara Wells, Jörn M. Schattenberg, Quentin M. Anstee, The LITMUS Investigators, Quentin M. Anstee, Ann K. Daly, Simon Cockell, Dina Tiniakos, Pierre Bédossa, Alastair D. Burt, Fiona Oakley, Heather J. Cordell, Christopher P. Day, Kristy Wonders, Paolo Missier, Matthew McTeer, Luke Vale, Yemi Oluboyede, Matt Breckons, Jo Boyle, Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Max Nieuwdorp, Adriaan G. Holleboom, Athanasios Angelakis, Joanne Verheij, Vlad Ratziu, Karine Clément, Rafael Patiño‐Navarrete, Raluca Pais, Valérie Paradis, Detlef Schuppan, Jörn M. Schattenberg, Rambabu Surabattula, Sudha Rani Myneni, Yong Ook Kim, Beate K. Straub, Antonio Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas, Evangelia Petsalaki, Mark Campbell, Chris Lelliott, Susan Davies, Matej Orešič, Tuulia Hyötyläinen ほか 138 名 - Nature Metabolism 2024 被引用: 229

  12. Fibrosis and alcohol-related liver disease

    著者: , - Journal of Hepatology 2019 被引用: 325

  13. A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures

    著者: , , , , , , , , , , , , - Nature Metabolism 2023 被引用: 150

  14. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

    著者: , , , , , , , , , , , , , , , , , , , - Nature Communications 2014 被引用: 617

  15. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Baki Topal, Karine Clément, Stefano Romeo, Vlad Ratziu, Tania Roskams, Ann K. Daly, Quentin M. Anstee, Matthias Trost, Anetta Härtlová - Journal of Hepatology 2021 被引用: 160

  16. Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2022 被引用: 153

  17. Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2021 被引用: 191

  18. Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Quentin M. Anstee, Elisabetta Bugianesi - Gut 2021 被引用: 202

  19. Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage

    著者: , , , , , , , , , , , , , , , , , , , , , - Gut 2018 被引用: 149

  20. The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elisabetta Bugianesi, Jörn M. Schattenberg, Quentin M. Anstee - Contemporary Clinical Trials 2020 被引用: 133

  21. The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines

    著者: , , , , , , , , , , , , , - Gut 2018 被引用: 336

  22. Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group

    著者: , , , , , , , , , , , , , , , , , , - Liver International 2022 被引用: 150

  23. Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease

    著者: , , , , , , , , , , , , , , , - JHEP Reports 2019 被引用: 132

  24. qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis

    著者: , , , , , , , , , , , , , , , , , , - Hepatology 2019 被引用: 120